Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $10.2950 (0.83%) ($10.2950 - $10.2950) on Thu. Dec. 21, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.24% (three month average) | RSI | 46 | Latest Price | $10.2950(0.83%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -1% a day on average for past five trading days. | Weekly Trend | EDIT declines -1.6% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) XBI(96%) IVE(92%) LIT(88%) VYM(88%) ARKG(87%) | Factors Impacting EDIT price | EDIT will decline at least -2.62% in a week (0% probabilities). VXX(-47%) VIXM(-37%) EDOC(-35%) BNDX(-32%) TBT(-17%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.62% (StdDev 5.24%) | Hourly BBV | -1.2 () | Intraday Trend | 0% | | | |
|
Resistance Level | $10.6 | 5 Day Moving Average | $10.57(-2.6%) | 10 Day Moving Average | $10.43(-1.29%) | 20 Day Moving Average | $10.6(-2.88%) | To recent high | -7.1% | To recent low | 64.5% | Market Cap | $639m | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |